Using multiple in vitro cell lines and in vivo mouse models, the authors reported that combining radiation therapy with the small molecule of Quercetin to target full-length androgen receptor and androgen receptor splice variant 7 (ARv7) lead to better efficacy to suppress prostate cancer progression.
[Journal of Experimental & Clinical Cancer Research]